Full Press Release Details
Regeneron Resumes Enrollment of FL and DLBCL Patients in Odronextamab Trials.
ZLAB
Regeneron Resumes Enrollment of FL and DLBCL Patients in Odronextamab Trials
Key Takeaway: Regeneron Resumes Enrollment of FL and DLBCL Patients in Odronextamab Trials